{"id":5021,"date":"2021-09-22T07:09:03","date_gmt":"2021-09-22T04:09:03","guid":{"rendered":"https:\/\/www.klimik.org.tr\/koronavirus\/?p=5021"},"modified":"2021-09-24T07:10:27","modified_gmt":"2021-09-24T04:10:27","slug":"fda-pfizer-biontech-covid-19-asisinin-ucuncu-dozunu-belirli-gruplar-icin-onayladi","status":"publish","type":"post","link":"https:\/\/www.klimik.org.tr\/koronavirus\/fda-pfizer-biontech-covid-19-asisinin-ucuncu-dozunu-belirli-gruplar-icin-onayladi\/","title":{"rendered":"FDA, Pfizer-BioNTech COVID-19 A\u015f\u0131s\u0131n\u0131n \u00dc\u00e7\u00fcnc\u00fc Dozunu Belirli Gruplar \u0130\u00e7in Onaylad\u0131"},"content":{"rendered":"<p><img decoding=\"async\" loading=\"lazy\" class=\"wp-image-86785 alignleft\" src=\"https:\/\/www.klimik.org.tr\/wp-content\/uploads\/2020\/01\/FDA_.png\" alt=\"\" width=\"48\" height=\"48\" \/><strong>ABD G\u0131da ve \u0130la\u00e7 \u0130daresi (FDA), iki doz Pfizer-BioNTech COVID-19 a\u015f\u0131s\u0131ndan en az alt\u0131 ay sonra takviye bir doz uygulanmas\u0131n\u0131 belirli gruplar i\u00e7in onaylad\u0131.<\/strong><\/p>\n<p>ABD G\u0131da ve \u0130la\u00e7 \u0130daresi, Pfizer-BioNTech COVID-19 a\u015f\u0131s\u0131n\u0131n acil kullan\u0131m yetkisini (EUA), a\u015fa\u011f\u0131da belirtilen gruplarda iki doz primer a\u015f\u0131dan en az alt\u0131 ay sonra uygulanacak tek bir takviye dozun kullan\u0131m\u0131na izin verecek \u015fekilde de\u011fi\u015ftirmi\u015ftir:<\/p>\n<ul>\n<li>65 ya\u015f ve \u00fcst\u00fc bireyler;<\/li>\n<li>\u015eiddetli COVID-19 ge\u00e7irme riski y\u00fcksek 18 ila 64 ya\u015f aras\u0131ndaki bireyler;<\/li>\n<li>Kurumsal veya mesleki nedenlerle SARS-CoV-2&#8217;ye s\u0131k s\u0131k maruz kalarak, \u015fiddetli COVID-19 dahil olmak \u00fczere COVID-19&#8217;un ciddi komplikasyonlar\u0131 a\u00e7\u0131s\u0131ndan y\u00fcksek risk alt\u0131na giren 18 ila 64 ya\u015f aras\u0131 bireyler.<\/li>\n<\/ul>\n<p>\u015eu anki yetkilendirme yaln\u0131zca Pfizer-BioNTech COVID-19 a\u015f\u0131s\u0131 i\u00e7in ge\u00e7erlidir.<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-authorizes-booster-dose-pfizer-biontech-covid-19-vaccine-certain-populations\"><strong>Haber \u0130\u00e7in T\u0131klay\u0131n\u0131z<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ABD G\u0131da ve \u0130la\u00e7 \u0130daresi (FDA), iki doz Pfizer-BioNTech COVID-19 a\u015f\u0131s\u0131ndan en az alt\u0131 ay sonra takviye bir doz uygulanmas\u0131n\u0131 belirli gruplar i\u00e7in onaylad\u0131. ABD G\u0131da ve \u0130la\u00e7 \u0130daresi, Pfizer-BioNTech COVID-19 a\u015f\u0131s\u0131n\u0131n acil kullan\u0131m yetkisini (EUA), a\u015fa\u011f\u0131da belirtilen gruplarda iki doz primer a\u015f\u0131dan en az alt\u0131 ay sonra uygulanacak tek bir takviye dozun kullan\u0131m\u0131na izin verecek \u015fekilde de\u011fi\u015ftirmi\u015ftir: 65 ya\u015f ve \u00fcst\u00fc bireyler; \u015eiddetli COVID-19 ge\u00e7irme riski y\u00fcksek 18 ila 64 ya\u015f aras\u0131ndaki bireyler; Kurumsal veya mesleki nedenlerle SARS-CoV-2&#8217;ye s\u0131k s\u0131k maruz kalarak, \u015fiddetli COVID-19 dahil olmak \u00fczere COVID-19&#8217;un ciddi komplikasyonlar\u0131 a\u00e7\u0131s\u0131ndan y\u00fcksek risk alt\u0131na giren 18 ila 64 ya\u015f [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":5022,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/5021"}],"collection":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/comments?post=5021"}],"version-history":[{"count":1,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/5021\/revisions"}],"predecessor-version":[{"id":5023,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/5021\/revisions\/5023"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media\/5022"}],"wp:attachment":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media?parent=5021"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/categories?post=5021"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/tags?post=5021"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}